中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2014年
8期
31-32,33
,共3页
顾朋%王海林%王萍菊%樊喜文
顧朋%王海林%王萍菊%樊喜文
고붕%왕해림%왕평국%번희문
经导管肝动脉化疗栓塞%盐酸格拉司琼%甲氧氯普胺%甲泼尼龙%栓塞综合征
經導管肝動脈化療栓塞%鹽痠格拉司瓊%甲氧氯普胺%甲潑尼龍%栓塞綜閤徵
경도관간동맥화료전새%염산격랍사경%갑양록보알%갑발니룡%전새종합정
Transcatheter arterial chemoembolization%Granisetron hydrochloride%Metoclopramide%Methylprednisolone%Embolism syndrome
目的:探讨盐酸格拉司琼三联药物对经导管肝动脉化疗栓塞(TACE)术后栓塞综合征的预防效果,为临床推广做出指导。方法:选择本院自2010年2月-2013年2月收治的98例行经导管肝动脉化疗栓塞的中晚期肝癌患者为研究对象,按照随机数字表法分为观察组和对照组,每组49例。对照组在术前给予盐酸格拉司琼静脉滴注,观察组在对照组的基础上再联合使用甲氧氯普胺和甲泼尼龙,对比观察两组患者术后恶心呕吐、腹痛等胃肠道反应以及发热的情况。结果:观察组患者术后恶心呕吐的胃肠道反应以及发热情况优良率明显优于对照组,两组比较差异均有统计学意义(P<0.05)。结论:盐酸格拉司琼联合甲氧氯普胺和甲泼尼龙对TACE术后栓塞综合征的预防效果显著,能大大降低患者的胃肠道反应以及发热情况,值得临床广泛推广。
目的:探討鹽痠格拉司瓊三聯藥物對經導管肝動脈化療栓塞(TACE)術後栓塞綜閤徵的預防效果,為臨床推廣做齣指導。方法:選擇本院自2010年2月-2013年2月收治的98例行經導管肝動脈化療栓塞的中晚期肝癌患者為研究對象,按照隨機數字錶法分為觀察組和對照組,每組49例。對照組在術前給予鹽痠格拉司瓊靜脈滴註,觀察組在對照組的基礎上再聯閤使用甲氧氯普胺和甲潑尼龍,對比觀察兩組患者術後噁心嘔吐、腹痛等胃腸道反應以及髮熱的情況。結果:觀察組患者術後噁心嘔吐的胃腸道反應以及髮熱情況優良率明顯優于對照組,兩組比較差異均有統計學意義(P<0.05)。結論:鹽痠格拉司瓊聯閤甲氧氯普胺和甲潑尼龍對TACE術後栓塞綜閤徵的預防效果顯著,能大大降低患者的胃腸道反應以及髮熱情況,值得臨床廣汎推廣。
목적:탐토염산격랍사경삼련약물대경도관간동맥화료전새(TACE)술후전새종합정적예방효과,위림상추엄주출지도。방법:선택본원자2010년2월-2013년2월수치적98례행경도관간동맥화료전새적중만기간암환자위연구대상,안조수궤수자표법분위관찰조화대조조,매조49례。대조조재술전급여염산격랍사경정맥적주,관찰조재대조조적기출상재연합사용갑양록보알화갑발니룡,대비관찰량조환자술후악심구토、복통등위장도반응이급발열적정황。결과:관찰조환자술후악심구토적위장도반응이급발열정황우량솔명현우우대조조,량조비교차이균유통계학의의(P<0.05)。결론:염산격랍사경연합갑양록보알화갑발니룡대TACE술후전새종합정적예방효과현저,능대대강저환자적위장도반응이급발열정황,치득림상엄범추엄。
Objective:To investigate the preventive effect of triple drug Granisetron hydrochloride in the use of embolism syndrome after transcatheter arterial chemoembolization,which made guidance for clinical application. Method:98 patients admitted to the hospital from February 2010 to February 2013 were divided into control group(given granisetron hydrochloride before surgery)and observation group(given metoclopramide and methylprednisolone based on control group),the embolism syndrome of two groups were compared. Result:The excellent rate of gastrointestinal reactions and fever situation of observation group were better than that of control group,and the difference between the two groups were all statistically significant(P<0.05). Conclusion:Granisetron hydrochloride which combine with metoclopramide and methylprednisolone have significant effect on preventing embolism syndrome after transcatheter arterial chemoembolization, which is worthy of clinical widely.